Addus HomeCare - ADUS Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ADUS shares.
View ADUS analyst ratings or view top-rated stocks.

5 analysts have issued 12 month price objectives for Addus HomeCare's shares. Their ADUS share price forecasts range from $101.00 to $130.00. On average, they expect the company's share price to reach $113.00 in the next year. This suggests a possible upside of 15.4% from the stock's current price.
View analysts price targets for ADUS or view top-rated stocks among Wall Street analysts.

Addus HomeCare's stock was trading at $99.49 on January 1st, 2023. Since then, ADUS shares have decreased by 1.6% and is now trading at $97.94.
View the best growth stocks for 2023 here.

Addus HomeCare saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 436,600 shares, an increase of 28.8% from the February 13th total of 339,100 shares. Based on an average daily volume of 86,700 shares, the days-to-cover ratio is currently 5.0 days. Approximately 2.8% of the company's shares are short sold.
View Addus HomeCare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our ADUS earnings forecast.

Addus HomeCare Co. (NASDAQ:ADUS) released its quarterly earnings data on Sunday, October, 31st. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.02. The business earned $216.66 million during the quarter, compared to analysts' expectations of $227.11 million. Addus HomeCare had a net margin of 4.84% and a trailing twelve-month return on equity of 8.58%. Addus HomeCare's quarterly revenue was up 11.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.69 earnings per share.

ETFs with the largest weight of Addus HomeCare (NASDAQ:ADUS) stock in their portfolio include Argent Mid Cap ETF (AMID), Invesco S&P SmallCap Health Care ETF (PSCH), Janus Henderson Small Cap Growth Alpha ETF (JSML), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), iShares U.S. Healthcare Providers ETF (IHF), iShares S&P Small-Cap 600 Growth ETF (IJT), SPDR S&P 600 Small Cap Growth ETF (SLYG) and Xtrackers S&P SmallCap 600 ESG ETF (SMLE).

91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Addus HomeCare's stock is owned by a variety of retail and institutional investors. Top institutional investors include Morgan Stanley (5.63%), Silvercrest Asset Management Group LLC (4.68%), Principal Financial Group Inc. (3.85%), Dimensional Fund Advisors LP (3.75%), WCM Investment Management LLC (3.19%) and Price T Rowe Associates Inc. MD (2.38%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham.
View institutional ownership trends.

Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ADUS stock can currently be purchased for approximately $97.94.

Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.58 billion and generates $951.12 million in revenue each year. The company earns $46.03 million in net income (profit) each year or $2.85 on an earnings per share basis.

The company employs 33,182 workers across the globe.

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707.